Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose IL-2 Therapy in Bipolar Depression
NCT04133233Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2020
- Primary completion
- May 2022
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of Inleusin in bipolar disorder (BD), sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2020; status: completed.
02
Drugs
Inleusin
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT04133233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04133233.